课题基金 / 基金详情

Glycated CD59 as a Biomarker for Diabetes

Glycated CD59 as a Biomarker for Diabetes
糖化 CD59 作为糖尿病生物标志物
批准号：
8074153
负责人：
JOSE A HALPERIN
金额：
$25.42万
依托单位：
HARVARD MEDICAL SCHOOL
依托单位国家：
美国
项目类别：
财政年份：
2010
资助国家：
美国
项目状态：
已结题
起止时间：
2010-07-01 至 2012-04-30
来源：
https://reporter.nih.gov/project-details/8074153
关键词：
AccountingAddressAdultAffectAfrican AmericanAgeAmericanAmputationAntibodiesArchivesBiological AssayBiological MarkersBiopsyBlindnessBloodBlood GlucoseBlood VesselsBudgetsCardiovascular DiseasesCardiovascular systemCaucasiansCaucasoid RaceCell ProliferationCessation of lifeChronicClinicalClinical DataClinical TrialsCollaborationsComplementComplement ActivationComplications of Diabetes MellitusCross-Sectional StudiesDataDatabasesDetectionDevelopmentDiabetes MellitusDiabetic AngiopathiesDiabetic NephropathyDiagnosisDiagnosticDiseaseDistalEquilibriumFamily history ofFiberFoot PainFreezingGlucoseGlycosylated hemoglobin AGoalsGoldGuidelinesHealthHealthcareHispanicsHome environmentHumanHyperglycemiaHypertensionImmunoassayIncidenceIndividualInflammationInsulinInsulin-Dependent Diabetes MellitusKidneyKidney DiseasesKidney TransplantationLaboratoriesLifeLimb structureLinkLiquid substanceLongitudinal StudiesMeasurementMeasuresMediatingMethodsMicroalbuminuriaMolecularMonitorMonoclonal AntibodiesMorbidity - disease rateMyocardial InfarctionMyocardial IschemiaNIH Program AnnouncementsNerveNeurologic ExaminationOrganOryctolagus cuniculusPainPathogenesisPatient MonitoringPatient RepresentativePatientsPeripheral Vascular DiseasesPersonsPlayPolyneuropathyPopulationPopulations at RiskPredictive ValuePreventionProteinsProteinuriaPublishingReagentRecording of previous eventsRelative RisksResearch DesignRiskRisk FactorsRoleSamplingScreening procedureSensorySeveritiesSkinSourceStagingStrokeTestingThrombosisTimeTissuesTranslationsUnited States National Institutes of HealthUrineValidationVascular DiseasesWorkabstractingamino groupbasebench to bedsideblood glucose regulationcohortcomplement systemcostdiabetes managementdiabeticdiabetic cardiomyopathydiabetic patientgenetic regulatory proteinglucose monitorglucose toleranceglycationglycemic controlhigh riskhuman diseasehuman subjecthuman tissueimpaired glucose toleranceinterestmacrovascular diseasemortalitynovelpre-clinicalpreventpublic health prioritiesresponsesuccesstoolvalidation studies

项目成果

JOSE A HALPERIN的其他基金

相似基金

相关文献

期刊论文(5)
专著(0)
科研奖励(0)
会议论文
The utility of plasma glycated CD59 in predicting postpartum glucose intolerance: A prospective study of women diagnosed with GDM during a period of universal GDM screening.
血浆糖化 CD59 在预测产后葡萄糖不耐受中的效用：一项针对在普遍 GDM 筛查期间诊断为 GDM 的女性的前瞻性研究。
DOI： 10.1111/dme.15121
发表时间： 2023
期刊： Diabetic medicine : a journal of the British Diabetic Association
影响因子： --
作者： [Bogdanet,Delia, Castillo,MichelleT, Doheny,Helen, Dervan,Louise, Luque-Fernandez,MiguelA, Halperin,Jose, O'Shea,PaulaM, Dunne,FidelmaP]
通讯作者： Dunne,FidelmaP
The ability of pGCD59 to predict adverse pregnancy outcomes: a prospective study of non-diabetic pregnant women in Ireland.
DOI： 10.1007/s00592-022-01983-z
发表时间： 2023-02
期刊： ACTA DIABETOLOGICA
影响因子： 3.8
作者： [Bogdanet, Delia, Castillo, Michelle Toth, Doheny, Helen, Dervan, Louise, Luque-Fernandez, Miguel Angel, Halperin, Jose A., O'Shea, Paula M., Dunne, Fidelma P.]
通讯作者： Dunne, Fidelma P.
Plasma glycated CD59 predicts postpartum glucose intolerance after gestational diabetes.
DOI： 10.1530/eje-21-0635
发表时间： 2021-10-11
期刊： European journal of endocrinology
影响因子： 5.8
作者： [Benhalima K, Ma DD, Laenen A, Mathieu C, Halperin JA]
通讯作者： Halperin JA
The Role of Early Pregnancy Maternal pGCD59 Levels in Predicting Neonatal Hypoglycemia-Subanalysis of the DALI Study.
DOI： 10.1210/clinem/dgac498
发表时间： 2022-11-23
期刊： The Journal of clinical endocrinology and metabolism
影响因子： --
作者： []
通讯作者：
Blood Levels of Glycated CD59, a Novel Biomarker to Assess Pregnancy-induced Glucose Intolerance
  • 批准号：
    9902416
  • 项目类别：
  • 资助金额：
    $69.78万
  • 财政年份：
    2019
  • 负责人：
    JOSE A HALPERIN
  • 依托单位：
    BRIGHAM AND WOMEN'S HOSPITAL
Blood Levels of Glycated CD59, a Novel Biomarker to Assess Pregnancy-induced Glucose Intolerance
  • 批准号：
    10599099
  • 项目类别：
  • 资助金额：
    $69.78万
  • 财政年份：
    2019
  • 负责人：
    JOSE A HALPERIN
  • 依托单位：
    BRIGHAM AND WOMEN'S HOSPITAL
Blood Levels of Glycated CD59, a Novel Biomarker to Assess Pregnancy-induced Glucose Intolerance
  • 批准号：
    10382406
  • 项目类别：
  • 资助金额：
    $69.78万
  • 财政年份：
    2019
  • 负责人：
    JOSE A HALPERIN
  • 依托单位：
    BRIGHAM AND WOMEN'S HOSPITAL
Human Studies on Blood Levels of Glycated CD59 as a Biomarker in Diabetes
  • 批准号：
    9116831
  • 项目类别：
  • 资助金额：
    $67.57万
  • 财政年份：
    2014
  • 负责人：
    JOSE A HALPERIN
  • 依托单位：
    BRIGHAM AND WOMEN'S HOSPITAL
海外基金